Related Experiment Videos
Relationship between obesity and B-type natriuretic peptide levels
James McCord1, Brian J Mundy, Michael P Hudson
1Henry Ford Heart and Vascular Institute, Henry Ford Health System, Detroit, Mich., USA.
Archives of Internal Medicine
|November 10, 2004
Summary
B-type natriuretic peptide (BNP) levels are inversely related to body mass index (BMI) in patients with and without congestive heart failure (CHF). However, BMI is not an independent predictor of BNP levels when CHF severity is known.
Area of Science:
- Cardiology
- Biomarkers
- Obesity Medicine
Background:
- The relationship between B-type natriuretic peptide (BNP) levels, body mass index (BMI), and congestive heart failure (CHF) as an emergency diagnosis remains unclear.
- Understanding these associations is crucial for accurate CHF diagnosis and management.
Purpose of the Study:
- To investigate the correlation between BNP levels and BMI in patients presenting with acute dyspnea.
- To determine if BMI is an independent predictor of BNP levels in patients with and without confirmed CHF.
Main Methods:
- Analysis of data from 1586 participants in the Breathing Not Properly Multinational Study with acute dyspnea.
- BNP values, self-reported height and weight (for BMI calculation), and adjudicated CHF diagnoses were used.
- Multivariate analysis was performed to identify independent predictors of log BNP.
Main Results:
- Congestive heart failure (CHF) was diagnosed in 46% of participants.
- A significant inverse correlation was observed between BMI and BNP levels (r = -0.34 with CHF, r = -0.21 without CHF; P < .001 for both).
- In a subgroup with CHF, BMI was not an independent predictor of log BNP, unlike Framingham score, eGFR, sex, NYHA class, and third heart sound.
Conclusions:
- BNP levels demonstrate an inverse relationship with BMI in patients, irrespective of CHF status.
- When detailed CHF severity is accounted for, BMI does not independently predict BNP levels, suggesting other factors are more influential in this context.